Overview

A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

Status:
Completed
Trial end date:
2015-04-16
Target enrollment:
Participant gender:
Summary
A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.
Details
Lead Sponsor:
Celgene
Celgene Corporation
Treatments:
Albumin-Bound Paclitaxel